Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. (ENDV) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ENDV · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2025Report Date: Mar 31, 2025Next Earnings Date
EPS & Revenue vs. Estimates
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q1 FY2026 | Mar 25, 2026 | — | — | — | — | — | — |
| ◌ Q4 FY2025 | Nov 14, 2025 | — | — | — | — | — | — |
| ◌ Q3 FY2025 | Aug 14, 2025 | — | — | — | — | — | — |
| — Q1 FY2025 | Mar 31, 2025 | — | -$0.00 | — | — | — | — |
| — Q4 FY2024 | Dec 31, 2024 | — | -$0.00 | — | — | — | — |
| — Q4 FY2024 | Nov 12, 2024 | — | $0.00 | — | — | — | — |
| — Q3 FY2024 | Aug 22, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q1 FY2024 | Mar 30, 2024 | — | -$0.00 | — | $0.00B | — | — |
Earnings Price Reaction
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2025 | Mar 31, 2025 | — | $0.00 | $0.00 | +100.00% |
| — Q4 FY2024 | Dec 31, 2024 | — | $0.00 | $0.00 | -20.00% |
| — Q4 FY2024 | Nov 12, 2024 | — | $0.00 | $0.00 | +0.95% |
| — Q3 FY2024 | Aug 22, 2024 | — | $0.00 | $0.00 | +10.00% |
| — Q1 FY2024 | Mar 30, 2024 | — | $0.00 | $0.00 | -12.90% |
| — Q4 FY2023 | Dec 30, 2023 | — | $0.01 | $0.01 | -5.75% |
| — Q4 FY2023 | Dec 28, 2023 | — | $0.01 | $0.01 | +20.71% |
| — Q3 FY2023 | Aug 21, 2023 | — | $0.01 | $0.01 | +17.82% |
About Earnings & Data Methodology
Endonovo Therapeutics, Inc. (ENDV) most recently reported earnings on March 31, 2025 for Q1 FY2025, posting EPS of $-0.00 (in line with the analyst consensus of —). The next ENDV earnings date is expected around September 1, 2026.
Each quarter, investors track ENDV earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ENDV revenue tab →
Frequently asked questions
ENDV earnings · 4 questionsEndonovo Therapeutics, Inc.'s next earnings report is expected around September 1, 2026. ENDV typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ENDV historically reports after market close (AMC).
▸ Source: FMP · Endonovo Therapeutics, Inc. SEC filings · US GAAP · Endonovo Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026